Navigation Links
Patient Navigators Boost Colon Screens in Urban Minorities
Date:4/4/2008

Personal interventions cut no-show rates 30%, study finds

FRIDAY, April 4 (HealthDay News) -- Two new studies make the case that more personal guidance and encouragement will help increase the numbers of low-income and minority patients getting recommended screening for colorectal cancer.

The studies, published in current issue of Clinical Gastroenterology and Hepatology, found problems with large "safety net" health-care systems serving urban populations and hope for patient intervention programs featuring "navigators" that guide patients through preparation for the procedure and encourage their attendance.

Colon cancer, when detected early, is one of the most treatable of all cancers, with a five-year survival rate of 90 percent. However, diagnosis in the most advanced stage of the disease causes that survival rate to drop only 10 percent. The American Gastroenterological Association Institute estimates 148,800 people will be diagnosed with colorectal cancer in 2008, and almost 50,000 will die from the preventable disease.

In the first study, a research team studied six months of endoscopy laboratory scheduling and procedure logs from Denver Health Medical Center. They found 41.7 percent of the 817 people scheduled for outpatient colonoscopies failed to show. Of those who did make their appointments, 30.2 percent did not prepare their bowel properly to take the examination.

According to the Denver study, such safety net systems traditionally have a large proportion of low-income and minority patients, and their colonoscopy no-show rates are "very high." The researchers said the rate of colonoscopy non-attendance at Denver Health is comparable to similar institutions in the United States but much greater than the no-show rate at non-safety-net systems.

"Because the rationale and required steps for completing colonoscopy are complex, individual intervention with patient navigators -- non-clinical individuals who are specially trained to navigate the health-care system -- may be particularly helpful. Published accounts show that they have been very successful in minority community health centers and public hospitals in the U.S.," Dr. Thomas D. Denberg, of the University of Colorado Denver School of Medicine, said in a prepared statement.

His point is supported by the second study in which researchers from Mount Sinai School of Medicine, in New York City, and the City University of New York provided 532 colonoscopy patients with a patient navigator. Of these patients, 67 percent went to their colonoscopies, and only 5 percent of them had inadequate bowel preparation. The no-show rate among urban minorities also fell from an average of 40 percent (prior to the navigator program) to 9.8 percent.

"Our results show that introducing a patient navigator is effective in increasing colonoscopy completion rates in urban minorities, which not only directly benefits the patient, but should translate into greater efficiency and cost savings for endoscopy units," Dr. Steven H. Itzkowitz, of Mount Sinai School of Medicine, said in a prepared statement.

More information

The National Cancer Institute has more about colorectal screening.



-- Kevin McKeever



SOURCE: American Gastroenterological Association Institute, news release, April 1, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Healthcare providers who discuss intimate piercings earn patients trust
2. Anemia Triples Risk of Local Recurrence in Breast Cancer Patients
3. The Quantum Group Announces Increased Patient Enrollment Following Medicare Advantage Open Enrollment Period
4. Better care for dementia patients through new funding
5. Patient charter ensures that reports on physicians are meaningful, reliable and fair
6. Antipsychotic Drugs of Little Benefit to Alzheimers Patients
7. Mayo Clinic Identifies Infection Risks for Patients with Inflammatory Bowel Disease
8. Lack of patient-provider discussion contributes to disparities in use of breast reconstruction
9. Patient charter ensures that reports on physicians are meaningful, reliable, and fair
10. URAC Announces Support for Principles of Disclosure Projects Patient Charter
11. AHIP Endorses Patient Charter to Guide Physician Performance Measurement, Reporting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2017)... ... July 21, 2017 , ... ... students improve their chances of acceptance to a residency in a United States ... earned degrees outside the U.S. , According to data released by the ECFMG®, ...
(Date:7/21/2017)... ... July 21, 2017 , ... West Dermatology is pleased ... Vu, PA-C. Beginning July 17, 2017, Ms. Vu will join West Dermatology’s large network ... experience in dermatology, skin cancer , and more. She graduated from the University ...
(Date:7/21/2017)... ... July 21, 2017 , ... How physicians and ... the rise, say researchers presenting their work at the American Orthopaedic Society ... combination of evaluating the patterns of change in concussion symptom presentation, diagnostic tools ...
(Date:7/20/2017)... ... July 20, 2017 , ... Acute myeloid leukemia (AML) is ... rapidly without treatment. Newly diagnosed patients face intense chemotherapy regimens and a stem ... With such a challenging diagnosis that requires immediate action, patients and caregivers ...
(Date:7/20/2017)... ... ... For individuals with extended hospital stays or who are residents of nursing ... specially designed to accommodate patients with a wide range of ailments or special needs, ... has invented the patent-pending PORTABLE ARM REST, a specially designed armrest that features many ...
Breaking Medicine News(10 mins):
(Date:7/12/2017)... and Company (NYSE: LLY ) has entered into ... litigation in the U.S. District Court for the Eastern District ... (tadalafil) unit dose patent. This patent was previously set ... agreement, Cialis exclusivity is now expected to end at the ... patent for Cialis is valid and infringed by companies seeking ...
(Date:7/11/2017)... 11, 2017  The global market for liquid biopsy ... $394.1 million in 2016.  Although in early stages, the ... in particular as a result of the gradual shift ... recent introduction of a significant number of new liquid ... of tumor biomarkers to guide treatment decisions. ...
(Date:7/11/2017)... July 11, 2017 Oramed Pharmaceuticals Inc. (NASDAQ: ... pharmaceutical company focused on the development of oral drug ... Drug Administration (FDA) has agreed to schedule an End-of-Phase ... IIb trial of its oral insulin capsule ORMD-0801 in ... trial met primary and secondary endpoints by indicating a ...
Breaking Medicine Technology: